Table 3.
Quetiapine XR (n = 179) | ||
---|---|---|
Number of Patients (%) | Number of AEs | |
AEs | 171 (95.5%) | 845 |
Drug-related AEs | 159 (88.8%) | 559 |
Deaths | 0 | – |
SAEs | 5 (2.8%) | 6 |
Drug-related SAEs | 2 (1.1%) | 2 |
AEs leading to discontinuation | 51 (28.5%) | 64 |
Drug-related AEs leading to discontinuation | 39 (21.8%) | 49 |
AEs adverse events, SAEs serious adverse events